A Chiral and Polar Single-Molecule Magnet: Synthesis, Structure, and Tracking of Its Formation Using Mass Spectrometry.

The solvothermal reaction of cobalt(II) sulfate with S, S-1,2- bis(1-methyl-1 H-benzo[ d]imidazol-2-yl)ethane-1,2-diol, (H2L), neutralized with triethylamine (Et3N) in a mixture of methanol and water (2:1), resulted in triangular red crystals of [CoII7(L)3(SO4)3(OH)2(H2O)9]·4H2O·3CH3OH (Co7). It is formed of chiral and polar clusters crystallizing in the R3 space group. Co7 consists of apex-shared asymmetric dicubane units where all of the metals adopt an octahedral coordination and the three ligands wrap diagonally around the unit. One end of the cluster is bonded by six water molecules and the other end by three monodentate sulfates. The head-to-tail packing through extended H-bonds leads to polar chains. The ligand has lost two protons, adopts a cis-conformation, and is coordinated to five metals around the waist of the dicubane. Electrospray ionization mass spectrometry (ESI-MS) of solutions of the reaction as a function of time reveals the possible step-by-step assembly process of the cluster: the initial product [CoII(HL)(SO4)]2- combines with CoSO4, forming [CoII2(HL)(SO4)2]2-, and then, upon addition of Et3N, dimerizes through a [OH]- bridge to [CoII4(HL)2(OH)(CH3OH)2(SO4)3]- followed by capture of one Co2+ and one CoSO4 to form [CoII6(L)2(OH)(CH3O)(SO4)4]2- before eventually binding to CoL to form [CoII7(L)3(OH)2(SO4)4]2-. These results allow us to propose a possible process for the formation of Co7, which is a good example for chiral multidentate chelating ligand-controlled assembly of clusters. Magnetization measurements as a function of the temperature, field, and ac-frequency reveal ferromagnetic coupled moments and single-molecule magnetism (SMM).

Shared genes between Alzheimer's disease and ischemic stroke.

AIMS: Although converging evidence from experimental and epidemiological studies indicates Alzheimer's disease (AD) and ischemic stroke (IS) are related, the genetic basis underlying their links is less well characterized. Traditional SNP-based genome-wide association studies (GWAS) have failed to uncover shared susceptibility variants of AD and IS. Therefore, this study was designed to investigate whether pleiotropic genes existed between AD and IS to account for their phenotypic association, although this was not reported in previous studies. METHODS: Taking advantage of large-scale GWAS summary statistics of AD (17,008 AD cases and 37,154 controls) and IS (10,307 IS cases and 19,326 controls), we performed gene-based analysis implemented in VEGAS2 and Fisher's meta-analysis of the set of overlapped genes of nominal significance in both diseases. Subsequently, gene expression analysis in AD- or IS-associated expression datasets was conducted to explore the transcriptional alterations of pleiotropic genes identified. RESULTS: 16 AD-IS pleiotropic genes surpassed the cutoff for Bonferroni-corrected significance. Notably, MS4A4A and TREM2, two established AD-susceptibility genes showed remarkable alterations in the spleens and brains afflicted by IS, respectively. Among the prioritized genes identified by virtue of literature-based knowledge, most are immune-relevant genes (EPHA1, MS4A4A, UBE2L3 and TREM2), implicating crucial roles of the immune system in the pathogenesis of AD and IS. CONCLUSIONS: The observation that AD and IS had shared disease-associated genes offered mechanistic insights into their common pathogenesis, predominantly involving the immune system. More importantly, our findings have important implications for future research directions, which are encouraged to verify the involvement of these candidates in AD and IS and interpret the exact molecular mechanisms of action.

The reciprocal link between EVI1 and miRNAs in human malignancies.

Ecotropic virus integration site-1 (EVI1) is an oncogenic transcription factor which locus on chromosome 3(3q26.2). Alterations in EVI1 functions correspond with poor prognosis in different cancers, underscoring their status for the clinical cancer phenotype. MicroRNAs(MiR)are a class of small non-coding RNA sequences. They post-transcriptionally influence mRNA sequence through imperfect pairing with the 3'-UTR. Moreover, a growing body of studies showed that miRNAs could regulate initiation and progression of human malignancies. Current studies have been described that identifies numerous microRNAs that can be modulated by EVI1. Interestingly, the expression level of EVI1 can also be regulated by microRNAs, thus forming a reciprocal link. Recent understanding of the functional roles of EVI1, microRNAs, and their interactions in human cancers are summarized. This review will help to define a relationship between EVI1 and microRNAs in human malignancies and develop novel therapeutic strategies.